Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
NCT ID: NCT05931237
Last Updated: 2023-07-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
39 participants
INTERVENTIONAL
2021-09-09
2021-11-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The participants (n=39) of this study are healthy adults aged between 23 and 63 years old and consumed cranberry extract rich in (poly)phenols for 4 days. Plasma, urine and feces were collected to quantify gut microbial (poly)phenols metabolites and to profile the fecal microbiota.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Cranberry and Agaves Extract on Microbiota and Intestinal Health
NCT03800277
The Effect of a Cranberry Beverage on Intestinal Permeability and Gastrointestinal Function in Generally Healthy Adults
NCT03957239
Effects of Cranberry Powder Supplements on Gut Microbiota Diversity and Metabolic Syndrome
NCT03754504
Effect of Raspberry on Gut Microbiota and Metabolic Syndrome
NCT03620617
Effect of a Single Dose of Cranberry Beverage on Inflammation and Oxidative Stress
NCT01780922
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cranberry extract capsules (PREBIOCRAN(TM))
Cranberry extract capsules consumed twice a day providing 82.3 mg of flavan-3-ols daily.
Cranberry extract capsules
Cranberry extract capsules (Prebiocran(TM))
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cranberry extract capsules
Cranberry extract capsules (Prebiocran(TM))
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Stable or no medication
* Stable diet
* Stable physical activity
Exclusion Criteria
* Antibiotic and/or probiotic use three months prior to the study
* Smokers
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Symrise
INDUSTRY
Laval University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yves Desjardins
Full professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Laval University
Québec, , Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Metacann
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.